10 new technologies tackling urgent challenges from autoimmune disease to cancer win funding from Blavatnik Biomedical Accelerator.

The team that performed first-of-its-kind surgery in 2024 has successfully transplanted another genetically edited pig kidney into a living person.

Procedure conducted by Harvard Medical School physician-scientists at Massachusetts General Hospital raises hopes about improving and saving lives amid human organ shortages and reducing health disparities associated with organ failure and transplantation.

Biologists at Harvard Medical School, with support from Biogen, have mapped protein networks in the human 'interactome'.